- $254.82m
- $100.86m
- $1.01bn
- 54
- 79
- 10
- 45
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,195 | 892 | 1,161 | 1,094 | 1,005 |
Cost of Revenue | |||||
Gross Profit | 421 | 320 | 478 | 415 | 323 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,197 | 929 | 1,048 | 1,055 | 1,081 |
Operating Profit | -2.33 | -36.8 | 113 | 39 | -75.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -19.1 | -62 | 90.1 | 34.5 | -67.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.6 | -66.8 | 371 | 28.8 | -53.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -14.6 | -66.8 | 371 | 28.8 | -53.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -14.6 | -66.8 | 371 | 28.8 | -53.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.059 | -0.263 | 2.28 | 0.202 | -0.34 |